Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GNOM vs RYOIX overlap: 20% of top holdings shared

Bottom line

How much do GNOM and RYOIX overlap?

20% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 23.7% of GNOM's assets and 16.7% of RYOIX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

GNOMRYOIX
Weight overlap (top 25)20%
Shared holdings6
Weight in shared holdings23.7%16.7%
Total positions5174
Expense ratio0.5%1.38%
Holdings as ofMay 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Holdings GNOM and RYOIX have in common

Holding% of GNOM% of RYOIXOverlap
Guardant Health, Inc.5.59%1.72%1.72%
Illumina, Inc.4.82%1.94%1.94%
Natera, Inc.4.15%2.12%2.12%
Vertex Pharmaceuticals Incorporated3.95%4.32%3.95%
Moderna, Inc.3.28%2.15%2.15%
Gilead Sciences, Inc.1.95%4.49%1.95%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GNOM

  1. Biomarin Pharmaceutical Inc. — 4.09%
  2. Arrowhead Pharmaceuticals, Inc. — 4.07%
  3. Legend Biotech Corp — 4.05%
  4. Praxis Precision Medicines Inc — 4.01%
  5. Twist Bioscience Corp — 3.97%
  6. CRISPR Therapeutics AG — 3.85%
  7. Veracyte Inc — 3.64%
  8. Qiagen N.V. — 3.54%
  9. BioNTech SE — 3.41%
  10. Bio-techne Corporation — 3.41%
  11. 10X Genomics Inc — 3.23%
  12. Beam Therapeutics Inc — 3.09%
  13. Bnyrepos — 3.05%
  14. Eli Lilly And Company — 2.32%
  15. Ultragenyx Pharmaceutical Inc — 2.25%

Only in RYOIX

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Regeneron Pharmaceuticals Inc — 2.93%
  4. Revolution Medicines Inc — 2.48%
  5. Alnylam Pharmaceuticals Inc — 2.36%
  6. Beone Medicines Ltd — 2.17%
  7. Biogen Inc — 2.13%
  8. Royalty Pharma Plc — 2.01%
  9. Insmed Inc — 1.79%
  10. United Therapeutics Corp — 1.72%
  11. Roivant Sciences Ltd — 1.66%
  12. Incyte Corp — 1.62%
  13. Viatris Inc — 1.55%
  14. Neurocrine Biosciences Inc — 1.52%
  15. Argenx Se — 1.48%

Asset mix

Asset typeGNOMRYOIX
Stocks99.9%99.6%
Repurchase agreements3.1%0.6%
Cash & short-term funds—0.6%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Country mix

CountryGNOMRYOIX
US99.1%85.8%
CH—3.3%
GB1.8%3.2%
IE—2.7%
HK2.0%—
BM—1.7%
NL—1.5%
DE—1.2%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do GNOM and RYOIX overlap?
About 20% by weight. 6 securities appear in both funds' top 25 holdings; they make up 23.7% of GNOM's assets and 16.7% of RYOIX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do GNOM and RYOIX have in common?
The largest shared holdings are Vertex Pharmaceuticals Incorporated, Moderna, Inc., Natera, Inc., Gilead Sciences, Inc., Illumina, Inc..
Should I own both GNOM and RYOIX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, GNOM or RYOIX?
RYOIX is broader, with 74 positions versus 51 for GNOM. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.